Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours Β· Estimated delivery Aug 13 - Aug 18
About Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) The Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) is an investigator-initiated study conducted as a multicenter, placebo-controlled, double-blind, randomized Phase III clinical trial to verify the efficacy and safety of high-dose methylcobalamin (mecobalamin) in patients with amyotrophic lateral sclerosis (ALS)
They could result in better learning and memory retention
In addition, in-situ TYR-catalyzed synthesis of Fluo was observed under CLSM (Supplementary Fig
doi: 10.3389/fphar.2025.1551843 Received 26 December 2024 Accepted 09 June 2025 Published 02 July 2025 Volume 16 - 2025 Edited by Ting Shen, Yangzhou University, China Reviewed by Shuo Yuan, University of Virginia, United States Yan Hu, Second Affiliated Hospital of Dalian Medical University, China Updates Copyright 2025 Mao, Huang, Li, Sun, Zhang, Cheng, Zeng, Lei, Wang and Yao
doi: 10.2165/00003088-200039020-00005 18 MccuneJ.GooleyT.GibbsJ.SandersJ.PetersdorfE.AppelbaumF.et al
US$ 26.67
US$ 25.17
US$ 27.32
US$ 20.27
US$ 23.07
US$ 26.67
US$ 28.36
US$ 22.02